Vir Biotechnology (VIR) Other Gross PP&E Adjustments (2018 - 2025)
Historic Other Gross PP&E Adjustments for Vir Biotechnology (VIR) over the last 8 years, with Q3 2025 value amounting to $35.9 million.
- Vir Biotechnology's Other Gross PP&E Adjustments fell 177.3% to $35.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.9 million, marking a year-over-year decrease of 177.3%. This contributed to the annual value of $38.0 million for FY2024, which is 5936.62% up from last year.
- Latest data reveals that Vir Biotechnology reported Other Gross PP&E Adjustments of $35.9 million as of Q3 2025, which was down 177.3% from $34.5 million recorded in Q2 2025.
- Vir Biotechnology's Other Gross PP&E Adjustments' 5-year high stood at $56.8 million during Q1 2024, with a 5-year trough of -$45.0 million in Q4 2021.
- Moreover, its 5-year median value for Other Gross PP&E Adjustments was $33.9 million (2024), whereas its average is $18.7 million.
- As far as peak fluctuations go, Vir Biotechnology's Other Gross PP&E Adjustments tumbled by 102468.51% in 2021, and later soared by 45757.58% in 2023.
- Vir Biotechnology's Other Gross PP&E Adjustments (Quarter) stood at -$45.0 million in 2021, then soared by 143.47% to $19.5 million in 2022, then increased by 22.06% to $23.9 million in 2023, then skyrocketed by 59.37% to $38.0 million in 2024, then fell by 5.57% to $35.9 million in 2025.
- Its Other Gross PP&E Adjustments was $35.9 million in Q3 2025, compared to $34.5 million in Q2 2025 and $39.9 million in Q1 2025.